EU cosmetic ingredients, restrictions and safety

Annex II Entry 230 15/10/2010

Guaifenesin (INN)

Guaifenesin (INN) is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.

Search similar Back to annex Compare

Prohibited substance— Annex II, EU Regulation 1223/2009

Entry: 230

Chemical identity and properties

PubChem 2D chemical structure for CAS 93-14-1

CAS 93-14-1PubChem CID 3516

Guaifenesin

Guaifenesin is a member of methoxybenzenes. — ChEBI

IUPAC name: 3-(2-methoxyphenoxy)propane-1,2-diol

Molecular formula: C10H14O4
Molecular weight: 198.22 g/mol
Exact mass: 198.08920892 Da
XLogP3: 1.4
Topological polar surface area: 58.9 Å²
Hydrogen-bond donors: 2
Hydrogen-bond acceptors: 4
Covalent units: 1
Defined stereocentres: 0

Also known as

GuaiphenesinGuaiacol glyceryl etherGlycerol guaiacolateGLYCERYL GUAIACOLATEGuaiphenesineMethphenoxydiolHustosilMucinex

16 more reported names

AeronesinCalmipanGuaiamarGuaianesinMyocaineRobitussinAresolDilynResylRelaxil GGuaiacuranGuaiacuraneGuajacuranGuayanesinReorganinMyoscain

Open full PubChem record PubChem annotations 3D structure image

External database identifiers

ChEBI:CHEBI:5551
ChEMBL:CHEMBL980
EPA DTXSID:DTXSID5023114
PubMed:29238574
PubMed:26632082
PubMed:23825891
PubMed:22131621
PubMed:20671996
PubMed:19166957
PubMed:16197601
PubMed:16089243
PubMed:15842963
PubMed:15759201
PubMed:15673990
PubMed:14751382

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Record details

Chemical name

Guaifenesin (INN)

Chemical / IUPAC name

1,2-Propanediol, 3-(2-methoxyphenoxy)-

Regulatory information

Regulation

See every entry this act set

Key data

CAS

EC

Annex

Entry number

230

Direct matches are limited for this record, so nearby entries from Annex II are shown as well.

Annex II 229

Nearby record in the same annex

Mecamylamine (INN)

CAS: 60-40-2

EC: 200-476-1

Annex II 231

Nearby record in the same annex

Dicoumarol (INN)

CAS: 66-76-2

EC: 200-632-9

Annex II 228

Nearby record in the same annex

Isometheptene (INN) and its salts

CAS: 503-01-5

EC: 207-959-6

Annex II 232

Nearby record in the same annex

Phenmetrazine (INN), its derivatives and salts

CAS: 134-49-6

EC: 205-143-4

Annex II 227

Nearby record in the same annex

2-Methylheptylamine and its salts

CAS: 540-43-2

Annex II 233

Nearby record in the same annex

Thiamazole (INN)

CAS: 60-56-0

EC: 200-482-4

Annex II 226

Nearby record in the same annex

Dextromethorphan (INN) and its salts

CAS: 125-71-3

EC: 204-752-2

Annex II 234

Nearby record in the same annex

3,4-Dihydro-2-methoxy-2-methyl-4-phenyl-2H,5H-pyrano[3,2-c]-[1]benzopyran-5-one (cyclocoumarol)

CAS: 518-20-7

EC: 208-248-3

Annex II 225

Nearby record in the same annex

Coumetarol (INN)

CAS: 4366-18-1

EC: 224-455-1

Annex II 235

Nearby record in the same annex

Carisoprodol (INN)

CAS: 78-44-4

EC: 201-118-7

Annex II 224

Nearby record in the same annex

2-(4-Allyl-2-methoxyphenoxy)-N,N-diethylacetamide and its salts

CAS: 305-13-5

Annex II 236

Nearby record in the same annex

Meprobamate (INN)

CAS: 57-53-4

EC: 200-337-5

What Annex II means for Guaifenesin (INN)

Guaifenesin (INN) is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.

Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.

The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.

Compliance checklist

Verify this substance is absent from all raw materials and finished formulations.
Request absence confirmation or CoA from raw material suppliers.
Document the screening result in the Product Information File (PIF).

Frequently asked questions

Yes. Guaifenesin (INN) is listed in Annex II of EU Cosmetics Regulation 1223/2009 and is prohibited as an intentionally added cosmetic ingredient. Article 17 provides a narrow exception for unintended small quantities that are technically unavoidable under good manufacturing practice, provided the product remains safe under Article 3.

CAS 93-14-1 is the unique numerical identifier assigned to Guaifenesin (INN) by the Chemical Abstracts Service. In cosmetic compliance work, the CAS number is used to cross-reference the substance across regulatory databases, raw material specifications and safety assessment reports. Multiple EU annex entries may share the same CAS number if the same substance appears under different conditions or in different annexes.

Use the INCI Checker tool on this site to paste your full ingredient list (INCI) and scan it against all Annex II–VI entries. The tool highlights any ingredients that match restricted, prohibited or allergen-flagged records. This is useful for rapid compliance screening of finished product formulas or raw material declarations.

Open INCI Checker

Source note for Annex II record Guaifenesin (INN)

This page summarizes one Annex II record for Guaifenesin (INN) from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.

Use this record page to review Annex II conditions for Guaifenesin (INN), but confirm any final regulatory decision against the current official annex wording and source files.

View sources View updates

Tools & next steps

Check your formula

Paste a full INCI list to detect Guaifenesin (INN) and other flagged EU annex records in one pass.

Compare entries

Compare Guaifenesin (INN) side by side with another annex record to review differences in restrictions, concentrations and annex placement.

Browse the annex

See all records in Annex II and compare regulatory conditions across substances in this annex.